MARIA ABELEDA: Open Payments
NPI 1871554907 · WYTHEVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,110 in 63 payments from 8 companies in 2025. Trend: 2023 $1,681 · 2024 $1,397 · 2025 $1,110
Food & beverage: $1,110
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 17 | $319 |
| E.R. Squibb & Sons, L.L.C. | 13 | $294 |
| Alkermes, Inc. | 13 | $135 |
| Neurocrine BioSciences, Inc. | 7 | $135 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $110 |
| Teva Pharmaceuticals USA, Inc. | 5 | $74 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
Products named: COBENFY, INVEGA SUSTENNA, SPRAVATO, ARISTADA, INGREZZA, CAPLYTA, AUSTEDO XR, HETLIOZ.
Industry payments across VA — which companies pay providers there.
